BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 34067714)

  • 1. Patient-Derived Cancer Organoids for Precision Oncology Treatment.
    Pernik MN; Bird CE; Traylor JI; Shi DD; Richardson TE; McBrayer SK; Abdullah KG
    J Pers Med; 2021 May; 11(5):. PubMed ID: 34067714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
    Pamarthy S; Sabaawy HE
    Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.
    Golebiewska A; Hau AC; Oudin A; Stieber D; Yabo YA; Baus V; Barthelemy V; Klein E; Bougnaud S; Keunen O; Wantz M; Michelucci A; Neirinckx V; Muller A; Kaoma T; Nazarov PV; Azuaje F; De Falco A; Flies B; Richart L; Poovathingal S; Arns T; Grzyb K; Mock A; Herold-Mende C; Steino A; Brown D; May P; Miletic H; Malta TM; Noushmehr H; Kwon YJ; Jahn W; Klink B; Tanner G; Stead LF; Mittelbronn M; Skupin A; Hertel F; Bjerkvig R; Niclou SP
    Acta Neuropathol; 2020 Dec; 140(6):919-949. PubMed ID: 33009951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
    Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
    Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
    Zhou Z; Cong L; Cong X
    Front Oncol; 2021; 11():762184. PubMed ID: 35036354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.
    Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S
    Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Derived Organoids for In Vivo Validation of In Vitro Data.
    Kdimati S; Bürtin F; Linnebacher M; Mullins CS
    Methods Mol Biol; 2023; 2589():111-126. PubMed ID: 36255621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Surgical and Colonoscopy Tissue to Establish Colorectal Patient-derived Organoids.
    Chen H; Yang Y; Shi J; Yan T; Wang J; Yang Y; Lu Q; Feng H; Du J; Cao Z; Weygant N
    Curr Cancer Drug Targets; 2024; 24(5):546-555. PubMed ID: 37997804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response.
    Piro G; Agostini A; Larghi A; Quero G; Carbone C; Esposito A; Rizzatti G; Attili F; Alfieri S; Costamagna G; Tortora G
    Front Med (Lausanne); 2021; 8():793144. PubMed ID: 35004765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological Factors as Predictors for Establishment of Patient Derived Head and Neck Squamous Cell Carcinoma Organoids.
    de Kort WWB; Millen R; Driehuis E; Devriese LA; van Es RJJ; Willems SM
    Head Neck Pathol; 2024 Jun; 18(1):59. PubMed ID: 38940869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
    Saeki S; Kumegawa K; Takahashi Y; Yang L; Osako T; Yasen M; Otsuji K; Miyata K; Yamakawa K; Suzuka J; Sakimoto Y; Ozaki Y; Takano T; Sano T; Noda T; Ohno S; Yao R; Ueno T; Maruyama R
    Breast Cancer Res; 2023 Feb; 25(1):21. PubMed ID: 36810117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
    Kumari R; Xu X; Li HQ
    Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived functional organoids as a personalized approach for drug screening against hepatobiliary cancers.
    Li L; Selaru FM
    Adv Cancer Res; 2022; 156():319-341. PubMed ID: 35961704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances of Patient-Derived Organoids in Personalized Radiotherapy.
    Wang Y; Li Y; Sheng Z; Deng W; Yuan H; Wang S; Liu Y
    Front Oncol; 2022; 12():888416. PubMed ID: 35574360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies.
    Song H; Park JY; Kim JH; Shin TS; Hong SA; Huda MN; Kim BJ; Kim JG
    J Korean Med Sci; 2022 Jul; 37(28):e220. PubMed ID: 35851862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients.
    Zou Z; Lin Z; Wu C; Tan J; Zhang J; Peng Y; Zhang K; Li J; Wu M; Zhang Y
    Adv Sci (Weinh); 2023 Sep; 10(27):e2302640. PubMed ID: 37485650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived organoid culture in epithelial ovarian cancers-Techniques, applications, and future perspectives.
    Chan WS; Mo X; Ip PPC; Tse KY
    Cancer Med; 2023 Oct; 12(19):19714-19731. PubMed ID: 37776168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promises and Challenges of Organoid-Guided Precision Medicine.
    Bose S; Clevers H; Shen X
    Med; 2021 Sep; 2(9):1011-1026. PubMed ID: 34617071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.